Mary Ann Rasku

Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth

Brian F. Clem, Sucheta Telang, Amy Clem et al. · Molecular Cancer Therapeutics · 2008 · 430 citations

Metabolic Remodeling, Cancer Biology, Glucose Uptake +22

Transient T cell depletion causes regression of melanoma metastases

Mary Ann Rasku, Amy Clem, Sucheta Telang et al. · Journal of Translational Medicine · 2008 · 162 citations · Full text

Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanoma

Sucheta Telang, Mary Ann Rasku, Amy Clem et al. · BMC Cancer · 2011 · 73 citations · Full text

A phase II trial of biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, interferon, and digoxin in melanoma matients

Michael Khan, B. Taft, Mary Ann Rasku et al. · Journal of Clinical Oncology · 2007 · 10 citations

Digoxin Therapy, Phase Ii Trial, Medicine +15